Cilobamine

Overview

Cilobamine is an orally active antidepressant and a dopamine/norepinephrine reuptake inhibitor. Cilobamine increases the levels of Aniline hydroxylase and cytochrome P-450 in rat liver. Cilobamine promotes hypertrophy of the smooth endoplasmic reticulum in rat liver hepatocytes, increases relative liver weight and recoverable microsomal protein. Cilobamine produces stimulant and anxiogenic effects, and does not inhibit monoamine oxidase . Cilobamine can be used in the research of depression.

Application

Products | Products > Disease Areas > Depression | Products > Disease Areas > Anxiety or Fear-Related Disease | Products > Disease Areas > Liver Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Digestive System Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Monoamine Transporter | Products > Signaling Pathways > Dopamine Transporter | Products > Signaling Pathways > Cytochrome P450

Product Information

• Catalog No.: HY-183457
• CAS No.: 69429-84-1
• Molecular Formula: C17H23Cl2NO
• Molecular Weight: 328.28
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source